$1.02B in CY2024 Part D spend612K claims · 105K beneficiaries · 329 plans surveyed
Questions a plan sponsor actually asks.
What is Abiraterone used for?
Abiraterone acetate tablets are indicated in combination with prednisone for the treatment of patients with Metastatic castration-resistant prostate cancer (CRPC) Metastatic high-risk castration-se....
Is there a generic for Abiraterone?
Yes. 19 ANDAs filed at FDA, 12 generic manufacturers currently shipping.
How much does my plan pay for Abiraterone?
Across 329 Part D plans, Abiraterone averages $0.832/unit (NADAC). Lowest available: $0.832/unit. Highest in distribution: $0.832/unit.
Is Abiraterone on the FDA shortage list?
No. Abiraterone is not currently on the FDA Drug Shortage Database.
4 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.
Sources · every number above traces back.
Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (10 approvals on file) · NADAC unit costs: CMS NADAC weekly file (20 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.